Oral administration of glycine in the prevention of restenosis after coronary angioplasty. A double blind placebo controlled randomized feasibility trial evaluating safety and efficacy of glycine in the prevention of restenosis after angioplasty

Acute Cardiac Care

Volumn 8, Issue 1, 2006, Pages 58-64

  Khan, Muchtiar ^a   Ron Van Der Wieken, L ^a   Riezebos, Robert ^a   Tijssen, Jan ^b   Kiemeneij, Ferdinand ^a   Slagboom, Ton ^a   Laarman, Gert Jan ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Glycine; ISR; PCI

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCINE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; PLACEBO; STATINE DERIVATIVE; TICLOPIDINE; WARFARIN;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 33745713825     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/14628840600643383     Document Type: Article

References (26)

1. Gravanis MB, Roubin GS. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Hum Pathol. 1989;20:477-86.
2. Serruys PW, de Jaegere, Kiemeney F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease (Benestent I ). N Eng J Med. 1994;331:489-95.
3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease (STRESS). N Eng J Med. 1994;331:496-501.
4. Azar AJ, Detre K, Goldberg S, Kiemeneij F, Leon MB, Serruys PW, on behalf of the Benestent and stent Restenosis Study, A meta-analysis on the clinical and angiographic outcomes of stents versus PTCA in the different coronary vessel sizes in the Benestent-1 and Stress-1/2 trials. Circulation. 1995;92:1-475. Supplement I, abstract.
5. Topol EJ, Califf RM, Weisman HF, Willerson JT, et al. for the EPIC Investigators. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa intergrin for reduction of clinical restenosis: results at 6 months. Lancet. 1994;343:881-6.
6. Serruys PW, Foley DP, Hofling B, Simon R, et al., on behalf of the EUROCARE study group, Carvedilol for prevention of restenosis after directional coronary atherectomy. Circulation. 2000;101:1512-8.
7. Rodes J, Cote G, Lesperance J, Tardif JC, et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation. 1998;97:429-36.
8. Kalinowski M, Alfke H, Bergen S, Wagner HJ, et al. Comparative trial of local pharmacotherapy with L-arginine, r-hirudin and molsidomine to reduce restenosis after balloon angioplasty of restenotic rabbit iliac arteries. Radiology. 2001;219:716-23.
9. Riessen R, Isner JM. Prospects for site-specific delivery of pharmacological and molecular therapies. J Am Coll Cardiol. 1994;23:1234-44.
10. Kay IP, Wardeh AJ, Kozuma K, Serruys PW, et al. radioactive stents delay but do not prevent in stent neointimal hyperplasia. Circulation. 2001;103:14-7.
11. Waksman R, Bhargava B, White L, Kent K, et al. Intracoronary B-radiation therapy inhibits recurrence of instent restenosis. Circulation. 2001;101:1895-8.
12. Morice MC, Serruys PW, Sousa JE, et al. A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Eng J Med. 2002;346:1773-80.
13. Grube E, Siber MS, Hauptmann KE, et al. Prospective randomised, double blind comparison of NIRx stents coated with paclitaxel in a polymer carrier in de-novo coronary lesions compared with uncoated controls. Circulation. 2001;104:II-463.
14. Tanabe K, Serruys PW, Grube E, et al. In-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymere formulation. Circulation. 2003;107:559-64.
15. Tourneau T, Belle v. E, Corseaux D, Bertrand M, et al. Role of nitric oxide in re-stenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodelling. J Am Coll Cardiol. 1999;33:876-82.
16. Lee JS, Jacob HJ, Roberts JD, Zapol WM, Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon induced arterial injury. Circulation Research. 1996;78:337-42.
17. Quyyumi A, Dakak N, Mulcahy D, Panza JA, et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 1997;29:308-17.
18. Janero D, Ewing JF. Nitric oxide and post angioplasty restenosis: pathological correlates and therapeutic potential. Free Radical Biology & Medicine. 2000;29:1199-221.
19. Zhong Z, Arteel G, Conner H, Thurman RG, et al. Cyclosporin a increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol. 1998;275:F595-604.
20. Spittler A, Reissner C, Manhart N, et al. Glycine modulates cytokine production of human blood cell monocytes. Clin Nutr. 1997;16:19. Supplement 2, abstract.
21. Zhong Z, Jones S, Thurman RG, et al. Glycine minimizes reperfusion injury in the rat. Am J Physiol. 1996;270:g332-38.
22. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation. 1996;94:3098-102.
23. Niebauer J, Schwarzacher SP, Hayase M, Yeung AC, et al. Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis. Circulation. 1999;100:1830-5.
24. Quyyumi A, Dakak N, Diodati JG, Cannon III RO, et al. effect of L-arginine on human coronary endothelium dependent and physiologic vasodilatation. J Am Coll Cardiol. 1997;30:1220-7.
25. Adams M, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium dependent dilation in healthy young men. J Am Coll Cardiol. 1995;26:1054-61.
26. Kiemeneij F, Laarman GJ, Slagboom T, Wieken van der. Outpatient coronary stent implantation. J Am Coll Cardiol. 1997;29:323-7.